Introduction
============

The primary physiological functions of the urinary bladder are the storage of urine at relatively low intravesical pressure and its expulsion (voiding) at appropriate times. Within the bladder wall are various cell types whose complex interactions determine its functional and mechanical properties. The contractile properties of the bladder are controlled by descending central inhibition and activation which overlay a complex autonomous (spontaneous) activity. The latter is most readily characterized when the bladder is freed from central control (Van Duyl, [@B33]; Coolsaet et al., [@B7]; Sugaya and de Groat, [@B31]; Drake et al., [@B11],[@B12]; Gevaert et al., [@B15]). It is manifest as localized contractions and stretches of the bladder wall which can be enhanced by increases in intravesical volume or by applying a muscarinic receptor agonist at low concentrations (Gillespie et al., [@B16]; Lagou et al., [@B22]). Furthermore, spontaneous contractions contribute to the overall contractile properties of the bladder under physiological and pathological conditions such as the overactive bladder (Kinder and Mundy, [@B21]).

Much of our knowledge of spontaneous bladder activity has come from *in vitro* research using muscle strips and isolated cells that can yield information about cellular pathways and local intracellular interactions (Oh et al., [@B27]; Yamanishi et al., [@B34]; Hashitani et al., [@B18]; Buckner et al., [@B3]). However, autonomous pressure changes in the whole bladder are also dependent on its geometrical properties and interactions between different tissue layers. Thus, to interpret findings from small isolated preparations requires them to be validated with whole organ preparations. To date most of this work has used bladders from small rodents maintained in physiological saline environments (Drake et al., [@B11]; Gillespie et al., [@B16]; Fabiyi and Brading, [@B14]; Buyuknacar et al., [@B4]). Extrapolating findings generated using small laboratory animals to the physiology of urine storage and voiding in large animals and the clinical context is difficult, and requires validation as additional issues have to be reconciled such as: differences in the base-line physiological properties of larger bladders and experimental considerations (adequate tissue perfusion and environmental control). Studies have evaluated the urodynamic properties of pig *in vivo*, demonstrating comparable urodynamic (Sibley, [@B29]; Crowe and Burnstock, [@B8]; Mills et al., [@B25]; Moore and Brading, [@B26]) and structural (Dixon and Gosling, [@B10]; Teufl et al., [@B32]) characteristics to humans, and potential clinical relevance. A novel extracorporeal perfusion model using isolated pig urinary bladder has been used to study its contractile properties (Dittrich et al., [@B9]). The purpose of the present study was to further validate the technique, to develop it by including arterial drug administration and micromotion filming, and to evaluate its potential for study of the integrative physiology of the large animal bladder.

Materials and Methods
=====================

Pig bladder retrieval
---------------------

Female pig (*Sus scrofa domestica*, ∼6 months old) bladders were obtained from the local abattoir immediately *post mortem*. At the abattoir, the abdomen of the animal was opened using a longitudinal midline incision extending from the jugular notch to the pubic symphysis. The distal abdominal aorta and the branches supplying the bladder were identified and carefully dissected free. The bladder and associated vasculature were then excised and perfused with ice-cold Krebs' solution at 4°C until all blood was drained from the organ. The warm ischemic time between killing the animal and bladder retrieval did not exceed 35 min (mean 30 ± 5 min). The bladder was then placed in ice-cold physiological buffer and transported to the laboratory. The distal aorta was cannulated using a 14 gage needle (BD Vialon™) and redundant branches were ligated. Ethical approval was not required as the organs were obtained from animals killed for human consumption.

Perfusion system
----------------

Using a peristaltic pump (Watson--Marlow Pumps Group, UK), the bladder was perfused via the aortic catheter at a constant rate of 10 ml/min with freshly made Krebs' solution (mM: NaCl, 118.3; NaHCO~3~, 24.9; KCl, 4.7; MgSO~4~, 1.15; KH~2~PO~4~, 1.15; CaCl~2~1.9; [d]{.smallcaps}-glucose, 11.7, gassed with 95% O~2~/5% CO~2~, pH 7.38 ± 0.01, 36 ± 1°C). The optimum pump perfusion rate for the experimental protocol was determined by measuring the weights of the experimental bladders before and after the perfusion period. A small degree of edema was to be expected as the Kreb's solution used to perfuse the *ex vivo* bladders does not have a significant oncotic pressure. In early experiments as the whole bladder apparatus was being developed, we found that perfusion rates of 30 ml/min or above led to excessive edema. Below this rate, the weight increase was less than 20% over the 8-h perfusion period, so we did not consider it necessary to increase the oncotic pressure of the perfusion solution with albumin or dextran. The 10 ml/min perfusion rate we settled upon gave a good balance of sustained viability and minimal edema, and is in keeping with the mean peak bladder blood flows measured in male human bladders using an endoscopic laser Doppler probe (Kershen et al., [@B20]). The perfused bladder was maintained at 36 ± 1°C in a specially manufactured double-jacketed glass organ bath (Cambridge Glassblowing, UK). The perfusion medium was not re-circulated to ensure that the bladder received optimal levels of nutrients and oxygenation, whilst preventing the build up of metabolic end products. Intra-arterial perfusion pressure was monitored (below).

Intravesical and arterial pressure measurement
----------------------------------------------

For intravesical pressure, a 6 Ch urodynamic double-lumen catheter (Mediplus, UK) was inserted into the bladder via the left ureter and secured with a vicryl ligature. The right ureter was tied off to ensure isovolumetric conditions. A 14 Ch Foley catheter (Bard, UK) was also passed into the bladder through the urethra and secured in place to aid emptying and filling at 50 ml/min. To achieve different bladder volumes, the lumen was filled with pre-warmed Krebs' solution and allowed to equilibrate for 10 min. A 16-gage catheter (Portex®, Smiths Medical International Ltd., USA) was placed into the distal aorta via one of its branches for arterial pressure measurement. The perfusion pressure to maintain a constant rate of flow through the vascular tree was monitored to represent arterial pressure. The fluid-filled catheters were connected to external pressure transducers (MX960, Medex Inc., UK) which were fixed at a pre-determined reference height and zeroed to atmosphere prior to experimentation. This ensured that pressure measurements from all experiments were subject to the same hydrostatic component. Once catheterised, pressure recording was commenced immediately, but the bladder was left to equilibrate for 30 min before any manipulations. A Powerlab data acquisition system (AD Instruments, UK) was used to record continuously the pressures generated, and "Chart 7.0" software was used to analyze the acquired data.

Assessment of bladder viability
-------------------------------

### Histological assessment

Biopsies were taken from the bladder dome after 8 h of perfusion. The samples were fixed in 4% buffered formalin and then embedded in paraffin blocks. Sections (10 μm) were mounted on glass slides, stained with haematoxylin and eosin (H&E) and then examined by a histopathologist using light microscopy to assess for the presence of autolysis. Photomicrographs of representative samples were taken using a digital color camera system (Olympus, UK). At the end of each experiment, the quality of organ perfusion achieved was assessed by injecting methylene blue through the aortic cannula and visually assessing the extent and depth of staining of the bladder wall.

### Pharmacological viability

The pH of the perfusate before and after passage through the organ was sampled at 1 h intervals to determine if there were significant changes suggestive of tissue ischemia. To determine if the perfusion system was able to preserve the isolated bladder in a functional condition, the cholinergic agonist carbachol (Sigma, UK) and potassium chloride (KCl) were administered using both intra-arterial and intravesical routes.

#### Arterial drug administration

Drugs were administered as 1 ml boluses in the perfusate via the arterial cannula (as described by Dittrich et al., [@B9]). Increasing concentrations of carbachol (1 × 10^−6^ to 3 × 10^−3^ M) and KCl (20--200 × 10^−3^ M) were given to produce dose response curves. A 20 min washout period was allowed between doses.

#### Intravesical drug administration

We elected not to fill organs from empty, to reduce the confounding influence of acute distension, so bladders were filled with 100 ml of Krebs solution and allowed to equilibrate for 20 min. The need to achieve rapid distribution of the pharmacological agent throughout the intravesical compartment required a sufficient volume to achieve mixing into the volume already present, so 50 ml of Krebs' solution containing the drug were then instilled into the bladder to achieve the overall intravesical volume concentration required (carbachol: 1 × 10^−6^ to 3 × 10^−3^ M and KCl 20--200 × 10^−3 ^M). The bladder was equilibrated with each concentration of carbachol or KCl for 20 min. Removal of pharmacological agents was undertaken by using repeated bladder washouts for 20 min. For control experiments, carbachol and KCl were omitted from the 50 ml instillation.

Assessment of spontaneous activity
----------------------------------

To demonstrate the effect of intravesical volume and bladder wall stretch on spontaneous activity, bladders were filled with 50 ml increments from an initial volume of 150 ml (average minimum volume of urine retrieved from bladders after killing) to a maximum volume of 450 ml (average maximum volume of urine retrieved from bladders after killing). These volumes are in keeping with reported pig bladder volumes from previous studies (Sibley, [@B30]). To evaluate how volume protocols affect spontaneous activity, a comparison was made between bladders completely emptied and refilled to 150 ml with fresh Krebs versus bladders drained down to that volume after prior filling to 450 ml. The changes in base-line intravesical pressure and the amplitude and frequency of spontaneous activity were recorded at each volume.

Assessment of bladder wall movements
------------------------------------

From an overhead view of the organ bath, a camera (30FP7 Microsoft, UK) connected to the Powerlab data acquisition system (AD Instruments, UK) was used to film bladder wall movements. The movements in separate regions were assessed by measuring variation in separation of optical features (applied carbon particles) on the bladder surface, akin to a method described previously (Gillespie et al., [@B16]). The distance between pairs of carbon particles at low (150 ml) bladder volumes were measured. Synchronous variation in separation of multiple points in various regions of the bladder were assessed with analysis software (Labview, National Instruments, Austin, TX, USA) and correlated with the pressure fluctuations for the same time period.

Data analysis
-------------

Changes of intravesical pressure in response to intra-arterial carbachol or KCl administration were plotted as a percentage of the maximum increase for each concentration response curve (CRC). Individual EC~50~ values (molar concentrations producing half maximal response) were determined by non-linear regression curve fitting of CRCs using GraphPad "Prism" (San Diego, CA, USA) software; the mean EC~50 ~± SEM were calculated.

The amplitude and frequency of spontaneous contractions were assessed at different volumes of bladder filling and were compared statistically with values obtained at 150 ml using repeated measure ANOVA followed by Dunnett's *post hoc* test. The same analysis was undertaken for the basal intravesical pressure at the different bladder volumes. All data are presented as mean ± SEM and n represents the number of bladders used. The video recording experiments are primarily descriptive and were not amenable to statistical analysis.

Results
=======

Assessment of bladder viability
-------------------------------

### Tissue perfusion

Intra-arterial administration of methylene blue resulted in successful staining of the serosa, detrusor, and urothelium of the entire organ (Figures [1](#F1){ref-type="fig"}A,B), indicating adequacy of perfusion.

![**Top panel: Perfusion of the bladder with methylene blue through the internal iliac trunk showing effective distribution to the serosa, detrusor, and urothelium: (A) serosal staining, (B) internal staining**. Bottom panel: H&E stained sections from paraffin-embedded intact pig bladder dome biopsies after 8 h of perfusion. The fine chromatin structure demonstrates well-preserved tissue with no signs of autolysis in the urothelium **(C)**, sub-urothelium **(D)**, or smooth muscle cells **(C,D)**. SM, smooth muscle; BV, blood vessels; LP, lamina propria; CT, connective tissue; S, sub-urothelium; U, urothelium.](fphar-03-00052-g001){#F1}

### Histological assessment

Light microscopic examination of H&E stained bladder biopsies (*n *= 6) taken after 8 h of perfusion demonstrated well-preserved tissue architecture with no evidence of autolysis or necrosis (Figures [1](#F1){ref-type="fig"}C,D). The urothelial layer was preserved in samples taken at the end of the perfusion period, with an intact urothelium and no separation of the mucosa and muscle layers (Figures [1](#F1){ref-type="fig"}C,D). Muscle bundles were well-preserved with little evidence of edema, except in some of the bladders beyond 10 h of experimentation time; therefore the perfusion period was kept to a maximum of 8 h.

### Biochemical viability

The pH of the perfusate at bladder inflow and outflow showed no significant changes over the course of the experiment (inflow pH = 7.38 ± 0.01 versus outflow pH = 7.44 ± 0.01, *n* = 6, Student's paired *t*-test: *p* \> 0.05).

### Arterial drug administration

During the 8-h perfusion period, the bladders produced consistent contractile responses to arterial boluses of carbachol and KCl. After the period of equilibration, 1 × 10^−5^ M carbachol generated a pressure rise of 5.2 ± 2.0 cmH~2~O and this was not significantly different (*p* \> 0.05) from the response elicited at the end of the perfusion period (6.1 ± 2.6 cmH~2~O, *n* = 6), demonstrating the stability of the responses. Carbachol produced concentration-dependent rises in intravesical pressure (Figure [2](#F2){ref-type="fig"}A). Basal arterial pressure remained stable throughout the experimental period. A gradual rise in perfusion pressure was noted with increasing bladder volumes, but these reverted to basal levels on bladder emptying. The increase in perfusion pressure measured between empty and 450 ml bladder capacity was 10.4 ± 2.1 cmH~2~O. There were also contraction-dependent transient increases in arterial pressure occurring synchronously with agonist-induced changes in intravesical pressure under isovolumetric conditions (Figure [2](#F2){ref-type="fig"}B). Such increases in perfusion pressure did not occur when the bladders were allowed to empty during contraction, indicating an increase of vascular resistance due to the restriction of flow through blood vessels during contraction. The maximum response to carbachol was 63.2 ± 3.6 cmH~2~O at 1 × 10^−3^ M and the EC~50~ was 96.7 ± 22.7 × 10^−6^ M (Figure [2](#F2){ref-type="fig"}C). High-K solutions (KCl) also produced concentration-dependent increases in intravesical pressure. The maximum response to KCl was 21.0 ± 7.4 cmH~2~O and the EC~50~ was 136.4 ± 6.6 × 10^−3^ M. There were also contraction-dependent increases of arterial pressure, as with the carbachol contractions (data not shown).

![**Pressure traces from an isolated whole pig bladder following administration of increasing concentrations of carbachol (arrows) through the arterial route: (A) intravesical pressure and (B) arterial pressure (C) changes to intravesical pressure are expressed as a percentage of the maximum response to carbachol obtained for each bladder (*n* = 5)**.](fphar-03-00052-g002){#F2}

### Intravesical drug administration

Due to the acute effects of varying intravesical volume, we elected to deliver boluses of carbachol into an already part-filled bladder (100 ml), rather than administer entire volumes into a completely empty bladder. Figure [3](#F3){ref-type="fig"}A shows that infusion of a further 50 ml Krebs solution generated a small step change in pressure. Delivery of a similar bolus containing carbachol at the highest concentration used (3 ×10^−3^M) generated not just a volume related step change but also a subsequent ongoing contraction with augmented spontaneous pressure variations, Figure [3](#F3){ref-type="fig"}B. The effect of intravesical carbachol was reversible after washout. In contrast to carbachol, KCl did not stimulate bladder contractions at any concentration (data not shown).

![**Pressure traces derived from an isolated whole pig bladder following administration of: (A) intravesical Krebs' solution and (B) Krebs' solution containing 3 × 10^−3^ M carbachol**.](fphar-03-00052-g003){#F3}

Effect of bladder volume on intravesical base-line pressure and phasic contractions
-----------------------------------------------------------------------------------

After the 30 min period of equilibration, all bladders developed basal phasic contractions once filling commenced. Representative traces of spontaneous contractions at low and high bladder volumes are shown in Figure [4](#F4){ref-type="fig"}A. At steady-state after filling to a new volume, spontaneous contractions were counted for 5 min intervals and the following were recorded: frequency, base-line pressure and average contraction amplitude. The frequency of contraction was unaffected by filling to different volumes; values were 7.6 ± 0.6/min (*n* = 6) at 150 ml and 8.8 ± 0.3/min (*n* = 7) at 450 ml (*p* \> 0.05) (Figure [4](#F4){ref-type="fig"}D). Figures [4](#F4){ref-type="fig"}B,C show the variation of base-line pressure and mean spontaneous contraction amplitude between 150 and 450 ml intravesical volume. Base-line pressure increased significantly from 1.6 ± 0.9 cmH~2~O (*n* = 6) at 150 ml to 3.7 ± 1.3 cmH~2~O (*n* = 6) at 450 ml (*p* \< 0.01), representing a compliance of 142.9 ml/cmH~2~O. The amplitude of spontaneous contractions increased significantly from 0.4 ± 0.1 cmH~2~O (*n* = 6) at 150 ml to 1.4 ± 0.3 cmH~2~O (*n* = 6) at 450 ml (*p* \< 0.01).

![**Effect of changes to intravesical bladder volume on spontaneous contractions of isolated pig bladder**. **(A)** spontaneous contractions generated at low (150 ml) versus high (450 ml) bladder volumes. **(B)** base-line intravesical pressure **(C)** amplitude of spontaneous contractions and **(D)** frequency of spontaneous contractions. After filling to 450 ml, a comparison was also made between bladders that were emptied and refilled with 150 ml of fresh Krebs (150E) versus bladders drained down to 150 ml (150D). \**p* \< 0.05 and \*\**p* \< 0.01 versus the initial 150 ml intravesical volume. Data are presented as mean ± SEM.](fphar-03-00052-g004){#F4}

When the bladder was drained completely after the filling protocol and then refilled to 150 ml with fresh Krebs (150E), the base-line and spontaneous contraction amplitudes returned to their pre-filling values (Figures [4](#F4){ref-type="fig"}B,C). However, when the bladder volume was merely drained back down to 150 ml (150D) the amplitude of spontaneous contractions remained significantly (*p* \< 0.01) elevated compared to the initial 150 ml volume (Figure [4](#F4){ref-type="fig"}C). This was not the case for the base-line pressure (Figure [4](#F4){ref-type="fig"}B). As seen during filling, the frequency of spontaneous contractions was unaffected by these emptying maneuvers (Figure [4](#F4){ref-type="fig"}D). Arterial pressure rose throughout the filling protocol and returned to base-line on emptying back to 150 ml.

Assessment of micromotions
--------------------------

Video filming in the absence of any pharmacological stimulus revealed the presence of localized wall movements (micromotions) throughout the bladder surface occurring at a frequency similar to the recorded pressure fluctuations. Motions along fixed axes were measured as shown in Figure [5](#F5){ref-type="fig"}. No distinction between different parts of the bladder could be seen in terms of the nature of surface movements. Within the filmed surface, frequencies of micromotions in different areas were not exactly the same and two areas could show coincident contractions in phase at some point in time, but be out of phase at another time, i.e. traces (2) and (3) in Figure [5](#F5){ref-type="fig"}. The correspondence between micromotions and whole bladder pressure fluctuations was variable. At one extreme, large contractions in localized areas could generate obvious pressure fluctuations as exemplified in traces (2) and (3) at 20 s in Figure [5](#F5){ref-type="fig"}. However, at the other extreme pressure fluctuations could be absent despite clear contractions as can be seen in traces (1), (3), and (4) at 110 s. We summise that this variation in pressure reflects the summation of all movements of the bladder surface, contractile, or relaxing, visible to our camera or not.

![**Assessment of bladder wall movements using carbon particles applied to the serosal surface of the bladder as optical markers: (A) demonstrates a photograph of a bladder showing the position of six particles and five consequent axes labeled (1) to (5) and their correlation to (B) intravesical pressure fluctuations at 150 ml**. The graph shows changes in distance between pairs of carbon particles over a 3-min period for the five axes. The downward deflections represent shortening/contraction along the axis whilst the upward deflections represent elongation/relaxation.](fphar-03-00052-g005){#F5}

Discussion
==========

The primary aims of the project were to ascertain the viability of a large perfused bladder, demonstrate in principle drug administration by different routes, and quantify micromotion filming and its relation to fluctuations of intravesical pressure. The pig bladder is a useful practical alternative to human bladder for elucidating physiological principles of potential clinical relevance. We were able to confirm organ viability using histological, biochemical, and pharmacological parameters, and maintain physiological conditions for a sufficient time to make detailed observations on intravesical pressure and bladder wall movement.

With large animal whole organ preparations, there is a balance to be struck when determining the rate of tissue perfusion. Adequate oxygenation must be ensured, but care has to be taken as high rates of perfusion will lead to increasing tissue edema as a result of elevated hydrostatic pressures. The molecular diffusion distance is approximately 100--200 μm from a supplying capillary (Colton, [@B6]) and consequently excessive edema will negatively impact on the delivery of oxygen and nutrients at a cellular level. The rate of pump perfusion was therefore optimized by measuring bladder weights before and after the experimental period and adjusted according to the degree of edema that developed. Despite this, a small amount of tissue edema was inevitable as the Kreb's solution used for perfusion lacks colloid oncotic pressure. This effect could be reduced by the addition of albumin/Dextran, but it was important to establish the proof of principle that viability could be maintained before proceeding with more expensive experimental protocols.

Changes in intra-arterial pressure occurred despite a constant pump perfusion rate and these mirrored the changes to intravesical pressure. This demonstrates that intravascular resistance is directly related to bladder wall tension, as has been reported *in vivo* (Greenland and Brading, [@B17]). This is further evidenced by decreases in mean bladder blood flow seen in human detrusor muscle during bladder filling as measured using laser Doppler flow (Batista et al., [@B1]). Reassuringly, none of the experimental bladders exhibited marked and persistent increases in perfusion pressure (irrespective of bladder volume) as this has previously been shown to be indicative of reducing isolated organ viability (Belzer et al., [@B2]).

Arterial administration of drugs elicited consistent dose-dependent responses and consequently, we have established the potential of arterial administration to an isolated bladder model, as well as via serosal and vesical routes typically used in other isolated bladder models such as rodent and rabbit (Chun et al., [@B5]; Matsumoto et al., [@B23]). The scientific interest of route of drug administration results from an interpretation of their likely influences. The arterial route is likely to achieve direct exposure of the entire bladder wall, given the extensive vascular supply to the musculature and suburothelial space. All interacting cell types are thus likely to be influenced synchronously, giving a useful insight into integrative bladder physiology. The serosal route might achieve this in a thin-walled bladder, but limitations of diffusion would prevent it in a bladder wall as thick as a pig or human. The vesical route necessarily exposes the urothelium as the first point of contact, with other tissues being exposed subsequently, and only if the agent can diffuse through the urothelial barrier. If it is unable to cross the urothelium, any influence on contractile activity must be an indirect consequence of mediator release from the urothelium. This raises the possibility of evaluation of urothelial function by stimulating its urothelial surface and comparing responses with those elicited via the arterial route, and potentially using arterially administered drugs to elaborate on the nature of urothelial mediators released. The maximum contractile response to arterially administered potassium was substantially smaller than that for carbachol -- a difference which is also apparent in isolated detrusor muscle strips (Mills et al., [@B24]). When given intravesically, potassium elicited no contraction; we presume this indicates intact urothelial barrier function, and may be pertinent for designing experimental approaches to evaluate bladder pain syndrome, for which inappropriate urothelial permeability to potassium could be a mechanistic contributor (Parsons, [@B28]).

Different protocols were employed for the two routes of administration. Because arterial perfusion was continuous, drugs were introduced as boluses into the perfusate. Thus, the duration of exposure was determined by the perfusion rate, the rate of distribution through tissue, and the rate of washout. By contrast, the vesical route required controlled, slow drug instillation, and a more prolonged dwell-time, aiming for mixing with minimal disturbance, as the inevitable alteration of bladder volume is a confounding factor for interpretation. Thus, it was not possible to achieve equivalent dose exposure and timing of onset to enable direct comparison between the two routes of administration.

The bladder wall movements are in keeping with a previous observational study in pigs, which demonstrated an increase in amplitude of phasic contractions with no change in frequency in response to bladder filling (Coolsaet et al., [@B7]); in rodents, both amplitude and frequency increase with bladder filling (Drake et al., [@B12]; Lagou et al., [@B22]). The enhanced pressure fluctuations associated with filling might reflect a change in length-tension relationship of the bladder wall, stretch-activated myogenic responses, or local reflex activity (Lagou et al., [@B22]). It would also be interesting to evaluate whether the calcium changes mapped in rodent urothelium (Kanai et al., [@B19]) can be linked to the movements we have observed. We also evaluated any link between specific movements of the bladder wall to particular fluctuations in the pressure trace. This is difficult to achieve, as changes in intravesical pressure will be the result of the summation of all bladder wall movements, not solely from the proportion of the bladder surface being filmed. This is evidenced by the fact that on occasions, no obvious pressure changes were detected despite apparently substantial movements in the bladder wall. This is likely to be clinically relevant as the presence of exaggerated bladder wall movements without objective urodynamic pressure changes has been demonstrated in women with increased filling sensation (Drake et al., [@B13]).

Alongside the physiological relevance, the model described implicitly could be extrapolated to evaluate pathophysiology. Akin to approaches used in rodents, intravesical exposure to topical irritants or urothelial permeabilization could be evaluated in the isolated pig bladder. Bladder outlet obstruction in the pig has been used as a means of generating detrusor overactivity, as described by Greenland and Brading ([@B17]), and the current approach could be employed to supplement urodynamic data in such a model.

Our study differs from the previous report on isolated whole pig bladder experiments (Dittrich et al., [@B9]) in several aspects. The current study sought to establish both histological and pharmacological viability of the isolated perfused bladder. We used isovolumetric conditions, and were thereby able to examine the effects of alterations of bladder volume on physiological parameters. We also tracked bladder wall movements. The limitation of the technique is the unavoidable warm ischemia time between the death of the animal and retrieval of its bladder. This appears to have had little effect on the reproducible behavior of the bladders, or their histological and biochemical viability. Nonetheless, in aiming to study function of metabolically active cells, the need must be to minimize warm ischemia time.

In conclusion, this technique gives a valuable insight into the physiology of the large animal bladder which is likely to be more informative than rodent models as a means of gaining insight into clinical conditions such as overactive bladder and detrusor underactivity.

It confirms that large animal bladders can remain viable when perfused *in vitro*, and gives new experimental potential for elucidating the functional complexities of the integrative physiology of the bladder.
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